Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. The company is headquartered in Radnor, Pennsylvania. Show more

150 N. RADNOR CHESTER ROAD, RADNOR, PA, UNITED STATES, 19087, Radnor, PA, 19087, USA

BIOTECHNOLOGY

HEALTHCARE

Market Cap

2.30B

52 Wk Range

$14.26 - $47.65

Previous Close

$27.05

Open

$27.13

Volume

863,225

Day Range

$25.91 - $27.13

Enterprise Value

1.748B

Cash

138.3M

Avg Qtr Burn

-32.56M

Insider Ownership

0.67%

Institutional Own.

Qtr Updated

06/30/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Lorundrostat Details Hypertension	PDUFA Approval decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Lorundrostat Details Hypertension and comorbid chronic kidney disease (CKD)	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Lorundrostat Details Obstructive sleep apnea, Hypertension	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.